News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
House Democrats Introduce “Scientific Integrity Act”
Kerry Grens | Mar 3, 2017
Representatives follow the lead of senators in drafting a bill that would encourage federal scientists to share data.
Michigan State Court of Appeals Hears Arguments in PubPeer Litigation
Bob Grant | Oct 5, 2016
Attorneys representing pathologist Fazlul Sarkar and users of the post-publication peer review website present their cases regarding the constitutionality of subpoenaing for the identities of anonymous commenters.
Macchiarini May Face Involuntary Manslaughter Charges
Bob Grant | Jun 23, 2016
The embattled stem cell researcher faces a new investigation exploring his culpability in the deaths of two patients he treated.
Opinion: Brain Scans in the Courtroom
Andreas Kuersten | Nov 23, 2015
Advances in neuroimaging have improved our understanding of the brain, but the resulting data do little to help judges and juries determine criminal culpability.
Australian Court Upholds Patents on Human Genes
Molly Sharlach | Sep 8, 2014
The Federal Court of Australia rejected an appeal of a ruling that allows companies to patent isolated human genes.
Proposed Law Aims to Restrict Antibiotic Use on Farms
Kerry Grens | Aug 13, 2014
A measure moving through the California legislature requires farmers to obtain a prescription to administer antibiotics to livestock.
U.K. May Allow Mitochondrial Replacement
Kate Yandell | Mar 21, 2013
The country’s fertility regulator reported that the technique has “broad support.”
Memory Not Reliable, Court Says
Cristina Luiggi | Jul 30, 2012
New Jersey judges are now required to explain to jurors that the human memory is prone to errors.
Academics Win Patent Rights
Jef Akst | Apr 10, 2012
A judge says that government and university labs have to share the patent rights to the successful cancer drug Velcade.
Misconduct Hearing Granted
Hannah Waters | Mar 9, 2012
A cancer researcher charged with scientific misconduct in 2011 may have the right to present his defense—a rare occurrence under current regulations.